NCT01075321 2020-10-22Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed58 enrolled 12 charts
NCT00691652 2019-11-27Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaOHSU Knight Cancer InstitutePhase 1/2 Terminated2 enrolled 4 charts
NCT01165996 2019-03-04Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic SyndromeCase Comprehensive Cancer CenterPhase 1/2 Completed25 enrolled 13 charts
NCT00601718 2017-05-25Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaUniversity of WashingtonPhase 1/2 Completed29 enrolled 10 charts
NCT00052520 2017-03-29Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell TransplantationFred Hutchinson Cancer CenterPhase 1/2 Completed37 enrolled